BREVICON
(ethinyl estradiol and norethindrone)Standard Prescription
Prevention of menstruation:
Brevicon 1 tablet PO daily
Acute abnormal uterine bleed:
Brevicon 1 tablet PO__(frequency) x __ days
Brevicon 1 tablet PO daily
Acute abnormal uterine bleed:
Brevicon 1 tablet PO__(frequency) x __ days
Dosages
Prevention of menstrual bleeds in post-menarchal patients:
Acute abnormal uterine bleeding: (including break-through bleeding with leuprolide in oncology patients):
1 tablet TID-QID until cessation of bleeding then taper as tolerated to maintain control of bleeding
one tablet PO daily (continuous)
1 tablet TID-QID until cessation of bleeding then taper as tolerated to maintain control of bleeding
Mechanism of Action
Hormone; Oral contraceptive
Forms Supplied
tablet: 35 mcg ethinyl estradiol and 1 mg norethindrone
Comments
Contains higher estrogen content than other oral contraceptives.
Consider concurrent administration of an anti-emetic.
Not recommended if receiving bone marrow or stem cell transplant due to risk of hyperbilirubinemia and hepatic veno-occlusive disease.
May be safely administered with short courses (2-5 days) of tranexamic acid.
May be used for emergency contraception if levonorgestrel (Plan B) is unavailable. Levonorgestrel preferred due to effectiveness and safety profile.
Consider concurrent administration of an anti-emetic.
Not recommended if receiving bone marrow or stem cell transplant due to risk of hyperbilirubinemia and hepatic veno-occlusive disease.
May be safely administered with short courses (2-5 days) of tranexamic acid.
May be used for emergency contraception if levonorgestrel (Plan B) is unavailable. Levonorgestrel preferred due to effectiveness and safety profile.
References
143, 153, 413, 658, 661
Last Edited
2022-06-08 22:40:15